Development of Pyrimidine‐Substituted Schiff Base and Their Axially Silicon Phthalocyanines as Inhibitors of Acetylcholinesterase and Butyrylcholinesterase for Alzheimer's Disease Therapy

Ähnliche Einträge

• Chlorine‐Thymol Substituted Silicon (IV) Phthalocyanines: Synthesis, Characterization, and In Vitro Acetylcholinesterase (AChE)/Butyrylcholinesterase (BChE) Inhibitory Effect
  von: Ayse Aktas Kamiloglu, et al.
  Veröffentlicht: (2024)
• New Peripheral Pyridine‐Substituted Cobalt, Copper, and Manganese Phthalocyanines as Potential In Vitro Acetyl/Butyrylcholinesterase Inhibitors in the Treatment of Alzheimer's Disease
  von: Halise Yalazan, et al.
  Veröffentlicht: (2025)
• Dendritic, Water‐Soluble, and Nonaggregated Axially Substituted Silicon Phthalocyanine as Potential Endometrial Anticancer Agent
  von: Turgut Keles, et al.
  Veröffentlicht: (2024)
• Synthesis and Biological Properties of (Vinyloxy)Ethoxy‐Substituted Zinc Phthalocyanine
  von: Gökhan Turan, et al.
  Veröffentlicht: (2026)
• Synthesis and Several Biological Properties of Peripherally Hexyl Benzoate–Substituted Cu II , Ni II Phthalocyanines
  von: Fatma Aytan Kılıçarslan, et al.
  Veröffentlicht: (2025)